These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24431106)

  • 1. How MDMA's pharmacology and pharmacokinetics drive desired effects and harms.
    Michael White C
    J Clin Pharmacol; 2014 Mar; 54(3):245-52. PubMed ID: 24431106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN; Spigset O; Slørdal L
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A brief overview of the clinical pharmacology of "club drugs".
    Britt GC; McCance-Katz EF
    Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute and long-term effects of ecstasy].
    Salzmann J; Marie-Claire C; Noble F
    Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy: as harmful as heroin?
    Scott R
    J Law Med; 2009 Dec; 17(3):327-48. PubMed ID: 20169795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key interindividual determinants in MDMA pharmacodynamics.
    Papaseit E; Torrens M; Pérez-Mañá C; Muga R; Farré M
    Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):183-195. PubMed ID: 29303006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The agony with ecstasy: lessons from a recent rave.
    Hoo GW
    J Intensive Care Med; 2013; 28(4):259-61. PubMed ID: 22914795
    [No Abstract]   [Full Text] [Related]  

  • 10. MDMA: interactions with other psychoactive drugs.
    Mohamed WM; Ben Hamida S; Cassel JC; de Vasconcelos AP; Jones BC
    Pharmacol Biochem Behav; 2011 Oct; 99(4):759-74. PubMed ID: 21756931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review.
    Parrott AC
    Psychopharmacology (Berl); 2007 Apr; 191(2):181-93. PubMed ID: 17297639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA; Rosenberg H
    Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ecstasy toxicity].
    Reingardiene D
    Medicina (Kaunas); 2006; 42(6):519-23. PubMed ID: 16816548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Partying" hard: party style, motives for and effects of MDMA use at rave parties.
    M ter Bogt TF; Engels RC
    Subst Use Misuse; 2005; 40(9-10):1479-502. PubMed ID: 16048829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
    Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.
    Smith KM; Larive LL; Romanelli F
    Am J Health Syst Pharm; 2002 Jun; 59(11):1067-76. PubMed ID: 12063892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission.
    Simantov R; Peng W
    FEBS Lett; 2004 Apr; 563(1-3):3-6. PubMed ID: 15063713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.
    Dafters RI; Duffy F; O'Donnell PJ; Bouquet C
    Psychopharmacology (Berl); 1999 Jul; 145(1):82-90. PubMed ID: 10445376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use.
    Mørland J
    Toxicol Lett; 2000 Mar; 112-113():147-52. PubMed ID: 10720724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
    Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
    Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.